Eisai Threatens To End Pfizer Alliance On Aricept Following Wyeth Acquisition

TOKYO - Eisai announced that it "has the right" to terminate a product development and business alliance agreement for its Alzheimer's treatment Aricept (donepezil) if Pfizer acquires Wyeth